Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

Details for Australian Patent Application No. 2012216499 (hide)

Owner Genentech, Inc.

Inventors Goddard, Audrey; Gurney, Austin L

Agent Griffith Hack

Pub. Number AU-A-2012216499

Parent 2008202957

Filing date 29 August 2012

Wipo publication date 20 September 2012

International Classifications

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 Medicinal preparations containing peptides

A61K 38/17 Medicinal preparations containing peptides - from animals

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 1/04 Drugs for disorders of the alimentary tract or the digestive system

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/47 Peptides having more than 20 amino acids

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 19/00 Hybrid peptides

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/00 Enzymes, e.g. ligases (6.)

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

C12P 21/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

13 September 2012 Complete Application Filed

20 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216499

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216500-Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus

2012216498-Method of funding health costs of employees